Mesenchymal stem cells (MSC) and adipose-derived stem cells (ASC) were recently proposed for bone maxillo-facial reconstruction in association with biomaterials. For this application MSC must be ex-vivo expanded in order to obtain, for a given volume of implanted biomaterial, a relevant number of bone forming cells. Previously conducted pre-clinical studies suggested that a concentration of 6 × 108 ASC associated with 900 mg of anorganic bovine bone (ABB) could be effective for human maxillary sinus floor elevation. A keystone issue to guarantee the quality and safety of Advanced Therapy Medicinal Products containing expanded MSC and ASC is their chromosome stability in culture: this topic has been widely investigated and conflicting results have been published. Abnormal karyotype of human ex-vivo expanded MSC and ASC was found by some authors, while, at the same time, several other studies showed the MSC and ASC karyotype to be normal. It is therefore important that all the results obtained on MSC and ASC karyotype analysis be published. Given this context, the aim of this manuscript, aim of this manuscript is to verify the karyotype stability of ASC in view of their applications in clinical trials. ASC obtained from the adipose tissue of 4 donors were expanded over extended culture time. Based on previous ASC expansions we hypothesized to be able to obtain 6 × 108 cells by passage 7. Karyotype analysis of 30 metaphases was planned to be investigated at passage 2, 7, and 15 in all the cultures. No abnormalities were found in the karyotype of two donors at all the passages tested, while a translocation was found in 2 metaphases of a donor at passage 7, but not at passage 15, and in the fourth donor in 5 metaphases a trisomy was found at passage 15. Chromosomal abnormalities were detected only after extended ASC expansion. Whether these anomalies can be related to risk for the patient's safety will have to be demonstrated by in-vivo studies.
SzpalskiCWetterauMBarrJWarrenSM. Bone tissue engineering: Current strategies and techniques–part I: Scaffolds. Tissue Eng Part B Rev2012; 18: 246–57.
2.
SzpalskiCBarbaroMSagebinFWarrenSM. Bone tissue engineering: Current strategies and techniques–part II: Cell types. Tissue Eng Part B Rev2012; 18: 258–69.
3.
FriedensteinAJPiatetzkySIIPetrakovaKV. Osteogenesis in transplants of bone marrow cells. J Embryol Exp Morphol1966; 16:381–90.
4.
ZukPAZhuMMizunoHHuangJFutrellJWKatzAJBenhaimPLorenzHPHedrickMH. Multilineage cells from human adipose tissue: Implications for cell-based therapies. Tissue Eng2001; 7: 211–28.
5.
MarianiEFacchiniA. Clinical applications and biosafety of human adult mesenchymal stem cells. Curr Pharm Des2012; 18: 1821–45.
6.
PieriFLucarelliECorinaldesiGAldiniNNFiniMParrilliADozzaBDonatiDMarchettiC. Dose-dependent effect of adipose-derived adult stem cells on vertical bone regeneration in rabbit calvarium. Biomaterials2010; 31: 3527–35.
7.
AchilleVMantelliMArrigoGNovaraFAvanziniMABernardoMEZuffardiOBarosiGZeccaMMaccarioR. Cell-cycle phases and genetic profile of bone marrow-derived mesenchymal stromal cells expanded in vitro from healthy donors. J Cell Biochem2011; 112: 1817–21.
8.
BernardoMEZaffaroniNNovaraFCometaAMAvanziniMAMorettaAMontagnaDMaccarioRVillaRDaidoneMGZuffardiOLocatelliF. Human bone marrow derived mesenchymal stem cells do not undergo transformation after long-term in vitro culture and do not exhibit telomere maintenance mechanisms. Cancer Res2007; 67: 9142–9.
9.
BinatoRde Souza FernandezTLazzarotto-SilvaCDu RocherBMencalhaAPizzattiLBouzasLFAbdelhayE. Stability of human mesenchymal stem cells during in vitro culture: Considerations for cell therapy. Cell Prolif2013; 46: 10–22.
10.
BochkovNPNikitinaVABuyanovskayaOAVoroninaESGoldsteinDVKuleshovNPRzhaninovaAAChaushevIN. Aneuploidy of stem cells isolated from human adipose tissue. Bull Exp Biol Med2008; 146: 344–7.
11.
BochkovNPNikitinaVAVoroninaESKuleshovNP. Methodological guidelines for genetic safety testing of cell transplants. Bull Exp Biol Med2009; 148: 677–83.
12.
BochkovNPVoroninaESKosyakovaNVLiehrTRzhaninovaAAKatosovaLDPlatonovaVIGol'dshteinDV. Chromosome variability of human multipotent mesenchymal stromal cells. Bull Exp Biol Med2007; 143: 122–6.
13.
BuyanovskayaOAKuleshovNPNikitinaVAVoroninaESKatosovaLDBochkovNP. Spontaneous aneuploidy and clone formation in adipose tissue stem cells during different periods of culturing. Bull Exp Biol Med2009; 148: 109–12.
14.
ChoumerianouDMDimitriouHPerdikogianniCMartimianakiGRiminucciMKalmantiM. Study of oncogenic transformation in ex vivo expanded mesenchymal cells, from paediatric bone marrow. Cell Prolif2008; 41: 909–22.
15.
Crespo-DiazRBehfarAButlerGWPadleyDJSarrMGBartunekJDietzABTerzicA. Platelet lysate consisting of a natural repair proteome supports human mesenchymal stem cell proliferation and chromosomal stability. Cell Transplant2011; 20: 797–811.
16.
DahlJADuggalSCoulstonNMillarDMelkiJShahdadfarABrinchmannJECollasP. Genetic and epigenetic instability of human bone marrow mesenchymal stem cells expanded in autologous serum or fetal bovine serum. Int J Dev Biol2008; 52: 1033–42.
17.
GrimesBRSteinerCMMerfeld-ClaussSTraktuevDOSmithDReeseABremanAMThurstonVCVanceGHJohnstoneBHSleeRBMarchKL. Interphase FISH demonstrates that human adipose stromal cells maintain a high level of genomic stability in long-term culture. Stem Cells Dev2009; 18:717–24.
18.
IzadpanahRKaushalDKriedtCTsienFPatelBDufourJBunnellBA. Long-term in vitro expansion alters the biology of adult mesenchymal stem cells. Cancer Res2008; 68: 4229–38.
19.
Meza-ZepedaLANoerADahlJAMicciFMyklebostOCollasP. High-resolution analysis of genetic stability of human adipose tissue stem cells cultured to senescence. J Cell Mol Med2008; 12: 553–63.
20.
NikitinaVAChaushevaAIZhanataevAKOsipovaEYDurnevADBochkovNP. Assessment of DNA damage in human bone marrow cells and multipotent mesenchymal stromal cells. Bull Exp Biol Med2011; 151: 550–2.
21.
NikitinaVAOsipovaEYKatosovaLDRumyantsevSASkorobogatovaEVShamanskayaTVBochkovNP. Study of genetic stability of human bone marrow multipotent mesenchymal stromal cells. Bull Exp Biol Med2011; 150: 627–31.
22.
RaJCShinISKimSHKangSKKangBCLeeHYKimYJJoJYYoonEJChoiHJKwonE. Safety of intravenous infusion of human adipose tissue-derived mesenchymal stem cells in animals and humans. Stem Cells Dev2011; 20: 1297–308.
23.
SafwaniWKMakpolSSathapanSChuaKH. Long-term in vitro expansion of human adipose-derived stem cells showed low risk of tumourigenicity. J Tissue Eng Regen Med2012; 1–11.
24.
SpiropoulosATheodosakiMStefanakiKPaterakisGTzetisMGiannikouKPetrakouEDimopoulouMNPapassotiriouIRomaESKanavakisEGraphakosSGoussetisE. Rapid clinical-scale propagation of mesenchymal stem cells using cultures initiated with immunoselected bone marrow CD105+ cells. J Cell Mol Med2011; 15: 1983–8.
25.
TarteKGaillardJLatailladeJJFouillardLBeckerMMossafaHTchirkovARouardHHenryCSplingardMDulongJMonnierDGourmelonPGorinNCSensebeL. Clinical-grade production of human mesenchymal stromal cells: Occurrence of aneuploidy without transformation. Blood2010; 115: 1549–53.
26.
FerreiraRJIriodaACCunhaRCFranciscoJCGuarita-SouzaLCSrikanthGVNityanandSRosatiRChachquesJCde CarvalhoKA. Controversies about the chromosomal stability of cultivated mesenchymal stem cells: Their clinical use is it safe?Curr Stem Cell Res Ther2012; 7: 356–63.
27.
de GirolamoLLucarelliEAlessandriGAvanziniMABernardoMEBiagiEBriniATD'AmicoGFagioliFFerreroILocatelliFMaccarioRMarazziMParoliniOPessinaATorreML. Mesenchymal stem/stromal cells: A new “cells as drugs” paradigm. Efficacy and critical aspects in cell therapy. Curr Pharm Des2012;.
28.
MesimakiKLindroosBTornwallJMaunoJLindqvistCKontioRMiettinenSSuuronenR. Novel maxillary reconstruction with ectopic bone formation by GMP adipose stem cells. Int J Oral Maxillofac Surg2009; 38: 201–9.
29.
ShayestehYSKhojastehASoleimaniMAlikhasiMKhoshzabanAAhmadbeigiN. Sinus augmentation using human mesenchymal stem cells loaded into a beta-tricalcium phosphate/hydroxyapatite scaffold. Oral Surg Oral Med Oral Pathol Oral Radiol Endod2008; 106: 203–9.
30.
ZengDXiaLZhangWHuangHWeiBHuangQWeiJLiuCJiangX. Maxillary sinus floor elevation using a tissue-engineered bone with calcium-magnesium phosphate cement and bone marrow stromal cells in rabbits. Tissue Eng Part A2012; 18: 870–81.
31.
ZouDGuoLLuJZhangXWeiJLiuCZhangZJiangX. Engineering of bone using porous calcium phosphate cement and bone marrow stromal cells for maxillary sinus augmentation with simultaneous implant placement in goats. Tissue Eng Part A2012; 18: 1464–78.
32.
CavalloCCuomoCFantiniSRicciFTazzariPLLucarelliEDonatiDFacchiniALisignoliGFornasariPMGrigoloBMoroniL. Comparison of alternative mesenchymal stem cell sources for cell banking and musculoskeletal advanced therapies. J Cell Biochem2011; 112: 1418–30.
33.
De UgarteDAMorizonoKElbarbaryAAlfonsoZZukPAZhuMDragooJLAshjianPThomasBBenhaimPChenIFraserJHedrickMH. Comparison of multilineage cells from human adipose tissue and bone marrow. Cells Tissues Organs2003; 174: 101–9.
34.
MuschlerGFNittoHBoehmCAEasleyKA. Age- and gender-related changes in the cellularity of human bone marrow and the prevalence of osteoblastic progenitors. J Orthop Res2001; 19: 117–25.
35.
QuartoRMastrogiacomoMCanceddaRKutepovSMMukhachevVLavroukovAKonEMarcacciM. Repair of large bone defects with the use of autologous bone marrow stromal cells. N Engl J Med2001; 344: 385–6.
36.
KitohHKitakojiTTsuchiyaHKatohMIshiguroN. Transplantation of culture expanded bone marrow cells and platelet rich plasma in distraction osteogenesis of the long bones. Bone2007; 40: 522–8.
